Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Not Confirmed
Not Confirmed
28 October-01 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Industry Trade Show
Not Confirmed
28 October-01 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
19 Jun 2024
// FIERCE PHARMA
https://www.fiercepharma.com/marketing/ucb-bangs-drum-epilepsy-drug-videos-about-sound-profound-seizure-reduction
29 Mar 2022
// E. Sagonowsky PHARMAPHORUM
https://pharmaphorum.com/news/ucb-takes-on-jazz-in-severe-epilepsy-with-new-fintepla-approval/
04 Mar 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/03/04/2397124/0/en/Zogenix-To-Present-New-Long-term-Data-on-FINTEPLA-fenfluramine-in-Lennox-Gastaut-Syndrome-LGS-at-AAN-2022.html
28 Feb 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/02/28/2393133/0/en/Zogenix-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results.html
02 Feb 2022
// Z. Brennan ENDPTS
https://endpts.com/zogenix-pulls-controversial-opioid-zohydro-er-from-the-market-ahead-of-ucb-acquisition/
20 Jan 2022
// B. Fidler BIOPHARMADIVE
https://www.biopharmadive.com/news/ucb-zogenix-acquire-deal-epilepsy-drug/617337/
Inspections and registrations
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?